GI
PACB icon

GAMCO Investors’s Pacific Biosciences PACB Stock Holding History

GAMCO Investors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100,000
Closed -$987K – 900
2020
Q3 		$987K Sell
100,000
-266,110
-73% -$1.53M 0.01% 570
2020
Q2 		$1.26M Sell
366,110
-8,000
-2% -$27.2K 0.01% 532
2020
Q1 		$1.15M Sell
374,110
-35,314
-9% -$145K 0.01% 525
2019
Q4 		$2.1M Sell
409,424
-38,164
-9% -$194K 0.02% 491
2019
Q3 		$2.31M Sell
447,588
-10,368
-2% -$58K 0.02% 467
2019
Q2 		$2.77M Sell
457,956
-4,278
-0.9% -$30K 0.02% 457
2019
Q1 		$3.34M Buy
462,234
+132,784
+40% +$960K 0.03% 413
2018
Q4 		$2.44M Buy
+329,450
New +$2.09M 0.02% 431

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

GAMCO Investors's PACB Position: Q4 2020 in Review

GAMCO Investors sold out of Pacific Biosciences (PACB) in Q4 2020, closing a stake of 100,000 shares — an estimated $987K sold.

GAMCO Investors first reported a position in PACB in Q4 2018 and held it in 8 quarters. The position peaked at $3.34M in Q1 2019. 210 funds tracked by Wall St. Rank hold PACB as of Q4 2020.

  • GAMCO Investors reported no remaining Pacific Biosciences position as of Q4 2020 after selling out during the quarter.
  • GAMCO Investors sold 100,000 Pacific Biosciences shares in Q4 2020, an estimated $987K.
  • GAMCO Investors first reported a position in Pacific Biosciences in Q4 2018 and held it in 8 quarters.
  • GAMCO Investors's Pacific Biosciences position peaked at $3.34M in Q1 2019.
  • 210 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2020.

Based on GAMCO Investors's 13F filing for Q4 2020, filed 5 Feb 2021.